MIR223 host gene (MIR223HG)

MIR223 host gene (MIR223HG), also known as linc-223 or linc223, is a long noncoding RNA (lncRNA) that serves as the primary transcript for microRNA-223 (miR-223), which is embedded within its sequence[1][2]. MIR223HG itself does not encode a protein or serve as a classical drug target, receptor, transporter, or enzyme. Instead, its biological significance is primarily as a transcriptional unit that is processed to generate miR-223, a well-characterized microRNA active in myeloid lineage differentiation, immune regulation, and inflammation[1][2]. Most functional and therapeutic interest is directed toward miR-223 rather than MIR223HG itself. There is no established evidence that MIR223HG by itself is a direct therapeutic target or that drugs interact directly with this lncRNA transcript. Clarification: Most literature about "MIR223" focuses on the microRNA (miR-223), not the lncRNA host gene ("MIR223HG" or "linc-223"). The host gene is not considered a classical therapeutic target, and its role is generally limited to facilitating the production of mature microRNA-223 via transcriptional processing[1][2]. If the intent was to reference the mature microRNA (miR-223), that is a separate entity with wide biological roles and clinical interest.

Other names

linc-223linc223MIR223HG